Page last updated: 2024-10-24

chetomin and Triple Negative Breast Neoplasms

chetomin has been researched along with Triple Negative Breast Neoplasms in 1 studies

chetomin: C31H30N6O6S4, similar to epipolythiodioxopiperazines
chetomin : An organic heteropentacyclic compound of the class of epipolythiodioxopiperazine. Isolated from Chaetomium globosum and Farrowia seminuda, it exhibits immunosuppressive activity.

Triple Negative Breast Neoplasms: Breast neoplasms that do not express ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and do not overexpress the NEU RECEPTOR/HER-2 PROTO-ONCOGENE PROTEIN.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dewangan, J1
Srivastava, S1
Mishra, S1
Pandey, PK1
Divakar, A1
Rath, SK1

Other Studies

1 other study available for chetomin and Triple Negative Breast Neoplasms

ArticleYear
Chetomin induces apoptosis in human triple-negative breast cancer cells by promoting calcium overload and mitochondrial dysfunction.
    Biochemical and biophysical research communications, 2018, 01-08, Volume: 495, Issue:2

    Topics: Antineoplastic Agents; Apoptosis; Calcium; Cell Line, Tumor; Disulfides; Dose-Response Relationship,

2018